United States · FDA National Drug Code directory
LORAZEPAM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-1138_06d08e7e-672a-4d3f-9e52-193b9d71fd82
- Product NDC
- 71335-1138
- Form
- TABLET
- Composition / generic term
- LORAZEPAM
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170324
- Source listing expiry
- 20271231
Source-listed ingredients
- LORAZEPAM — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (71335-1138-1) · 71335-1138-1
- 60 TABLET in 1 BOTTLE (71335-1138-2) · 71335-1138-2
- 40 TABLET in 1 BOTTLE (71335-1138-3) · 71335-1138-3
- 2 TABLET in 1 BOTTLE (71335-1138-4) · 71335-1138-4
- 90 TABLET in 1 BOTTLE (71335-1138-5) · 71335-1138-5
- 6 TABLET in 1 BOTTLE (71335-1138-6) · 71335-1138-6
- 120 TABLET in 1 BOTTLE (71335-1138-7) · 71335-1138-7
- 10 TABLET in 1 BOTTLE (71335-1138-8) · 71335-1138-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →